Apricus Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$451K Hold
900
0.22% 79
2026
Q1
$442K Sell
900
-40
-4% -$21.7K 0.22% 78
2025
Q4
$545K Buy
940
+22
+2% +$12.4K 0.28% 68
2025
Q3
$445K Buy
918
+94
+11% +$43.8K 0.24% 76
2025
Q2
$334K Hold
824
0.19% 80
2025
Q1
$410K Buy
824
+224
+37% +$121K 0.24% 70
2024
Q4
$312K Buy
600
+163
+37% +$89.6K 0.2% 77
2024
Q3
$271K Hold
437
0.18% 79
2024
Q2
$242K Buy
+437
New +$250K 0.17% 80
2024
Q1
Sell
-391
Closed -$208K 95
2023
Q4
$208K Buy
+391
New +$189K 0.16% 85
2023
Q2
Sell
-352
Closed -$203K 85
2023
Q1
$203K Sell
352
-108
-23% -$60.9K 0.19% 78
2022
Q4
$253K Sell
460
-10
-2% -$5.3K 0.23% 74
2022
Q3
$238K Sell
470
-3
-0.6% -$1.68K 0.24% 71
2022
Q2
$257K Sell
473
-24
-5% -$13.2K 0.24% 74
2022
Q1
$294K Buy
+497
New +$286K 0.24% 74

Other funds holding TMO

Apricus Wealth's TMO Position: Q2 2026 in Review

Apricus Wealth held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 900 shares worth $451K. The position accounts for 0.22% of the portfolio, ranked #79.

Apricus Wealth first reported a position in TMO in Q1 2022 and has held it in 15 quarters since. The position peaked at $545K in Q4 2025. 888 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Apricus Wealth held 900 shares of Thermo Fisher Scientific worth $451K as of Q2 2026.
  • Apricus Wealth left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.22% of Apricus Wealth's portfolio in Q2 2026, its #79 holding.
  • Apricus Wealth first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 15 quarters since.
  • Apricus Wealth's Thermo Fisher Scientific position peaked at $545K in Q4 2025.
  • 888 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Apricus Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.